IDEA Carlat Reports | Carlat Publishing Subscribe Register for free Content Cart Login Browse by Topic 13 Reasons Why ABA Abstinence Acamprosate Addiction Addiction Treatment Addyi Adhansia Adhansia XR ADHD ADHD Attention Deficit Hyperactivity Disorder ADHD Rating Scale-5 ADHD-RS-5 Adherence Adjunct treatment adolescents Aducanumab Aduhelm Adult ADHD Adverse Childhood Experiences (ACES) adverse events affective disorders Affordable Care Act (ACA) aggression Agitation Aid to capacity evaluation (ACE) AIMS test (Assessment of Involuntary Movement) air pollution Akathisia Alcohol alcohol abuse alcohol dependence Alcohol Poisoning Alcohol related liver disease Alcohol Use Alcohol use disorder alcohol- associated liver disease Alcoholism Alpha Agonists Altered Mental Status (AMS) Alternative treatments Alzheimers Amantadine amino acids amphetamine Amphetamines anabolic steroids Andro Androstenedione Anorexia Anorexia Nervosa Anti-NMDA Receptor Encephalitis Antibiotic Anticholinergic burden scale Anticholinergics anticonvulsants Antidepressant Antidepressant Augmentation Antidepressants antihistamines Antipsychotic Antipsychotics Anxiety Anxiety Disorder anxiety disorders APA CE Post-Test Apathy Applied Behavioral Analysis Aptensio ARFID Aripiprazole ArModafinil Asenapine Ashton manual Assault Assent Assessment assessments asthma atamoxetine Athletic performance Ativan Challenge Test Atomoxetine Atomoxetine (ATX) Atrophy Atropine attention Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Austedo Autism Autism Spectrum Disorder Autism Spectrum Disorder Autism Spectrum Disorder autism spectrum disorder Avoidant Restrictive Food Intake Disorder Beers criteria Behavior therapy Behavioral addiction Behavioral therapy Behavioral treatment Belsomra Benzodiazepine Benzodiazepines Benzphetamine Beta-blockers Billing Bipolar Depression Bipolar Disorder Bipolar II birth defects Black youth Bleeding Board Certification body mass index BMI body positivity Borderline Personality Disorder Boredom BPD BPSD (behavioral and psychological symptoms of dementia) Brain Devices Breastfeeding Brexpiprazole Brief psychotherapy brief pulse Brief Strategic Family Therapy (BFST) Bulimia Nervosa Bullying Bumetanide Buprenorphine Buprenorphine Induction Bupropion Bush-Francis Scale Buspirone C-Reactive Protein Caffeine CAM Treatments Cancer Cannabidiol Cannabis cannabis products cannabis use disorder cannabis withdrawal Capacity Caplyta Carbamazepine Cardiovascular Cariprazine Catatonia CATIE CBT CBTi Central Alpha Agonists CGI Chantix child abuse Child and adolescent Child Psychiatry Child Psychiatry childcare children children and adolescents Chlorpromazine Chokroverty Chromosomal Microarray circadian system Citalopram Clinical Global Impressions Clinical practice Clinical Practice Guidelines clonidine Clozapine CME Post-Test co-morbidities Co-occurring disorders Cocaine Cognition Cognitive Behavioral Therapy Cognitive Behavioral Therapy for Insomnia Cognitive Behavioral Therapy for Insomnia (CBTi) Cognitive Decline Cognitive functioning cognitive impact Cognitive impairment cognitive processing therapy Cognitive Rehabilitation Therapy (CRT) Collaboration Collaborative care Collateral data college mental health Combination treatment Combined Pharmacotherapy Commitment community trauma Comorbidity complementary medicine Complementary treatments Complimentary Medicine Complimentary treatments compulsions Computer addiction Computers in Psychiatric Practice Conduct Disorder Confidentiality Confusion Confusion Assessment Method (CAM) Connect Connection Connections Consensual Consent consult-liaison Contagion Contempla contingency management contraception contraceptive services control group Coronavirus Cosmetic pharmacology Countertransference court hearings COVID-19 COVID19 craving creatine creatine monohydrate Creativity Crime Criminal behavior Crisis intervention Crocus Sativus CRP CT Cultural Competence Culture custody agreement Cymbalta CYP2C19 CYP2D6 DASH diet DaT Scan Dayvigo De-escalation Debriefing Decisional Capacity Deep brain stimulation (DBS) Degarelix Deliberate foreign body ingestion Delirium Delusional Disorder Dementia Deplin Deprescribing Depression Depressive Disorder designer drugs Detoxification Deutetrabenazine Developmental Relationship Based Intervention DFBI Diabetes diabetes insipidus Diagnosis Diagnostic Testing Dialectical Behavioral Therapy diet Dietary Approaches to Stop Hypertension (DASH) Diethylpropion differential diagnosis Diphenhydramine Disaster Discrepancies Disinhibition Disorganization Disparities dispensary Dispositional capacity Disruptive Mood Dysregulation Disorder (DMDD) Disulfiram Divalproex Diversity Divorce DMDD Dopamine Dosage Timing Dose Response Dosing double blind Double blind trial DRBI Drooling Droperidol drug misuse Drug-assisted psychotherapy DSM Dual diagnosis Duloxetine duty to protect duty to warn Dyanaval Dyslexia Dysregulation E-Cigarettes Eating Disorders eating restriction eCigarettes ECT effect size Effexor efficacy EHR Electroconvulsive therapy Electronic Health Records electronic use Emergency Emergency Department emergent suicidality emotion dysregulation Emotional dysregulation EMPOWER trial Encephalitis End of Life Care endocrinological side effects Engagement Equine Assisted Psychotherapy Equine therapy Escitalopram Esketamine Estrogen Eszopiclone eTNS Evekeo excessive exercise Exercise Existing marijuana expressed emotion extended dosing extended-release Eye movement desensitization and reprocessing Fall risk Falls Family Separation Fast-acting fat shaming FDA FDA Warnings Female hypoactive sexual desire disorder Female Issues in Psychiatry fentanyl fetal effects First Generation Antipsychotics (FGAs) Flu Shot fluid restriction Fluoxetine fMRi Folate Folic Acid Fragile X Free Articles Frontotemporal dementia gabapentin GAD gambling GAMC Gastroenterology GDD Gender Gender & Sexuality Gender Affirming Medical Care Gender Diverse Gender Dysphoria Gender Dysphoric Disorder Gender Identity Generalized Anxiety Disorder Generics GeneSight Genetic Testing Genetics and Psychiatry Geriatric Geriatric Depression Scale (GDS) Geriatric Psychiatry Geriatrics Ginkgo GLP-1 Agonists Good Psychiatric Management Guanfacine Hair loss Haloperidol Harm reduction Head Trauma Health Apps Healthy aging Hearing loss Heart health Heart rate Hemorrhagic Hepatitis Heroin Higher-calorie refeeding HIPAA Histamine HIV Hormone Replacement Therapy hospital culture Hospital policy HRT huffing hydroxymethyl butyrate (HMB) Hydroxyzine hyperlipidemia hypersalivation hypersexual behaviors hypertension Hypnotics Hypomania Hyponatremia hypothyroidism IDEA Imaging Immune System Incarceration Inclusion Inclusion strategies Independent Educational Plan (IEP) induction infant Inflammation Influenza vaccination Ingrezza Inhalants Innovations Inpatient Psychiatry inquiry Insomnia Insulin resistance Insurance intermittent fasting Internet internet-based treatment interpersonal stressors Interpreter Intervention Intra-cerebral hemorrhage Intra-nasal involuntary civil commitment Irritability IV immunoglobulin therapy (IVIG) Jornay PM Keppra Ketamine l-methylfolate Laboratory Testing in Psychiatry lactation Lamictal Lamotrigine Language LATE Lavender Learning & Developmental Disabilities Least Restrictive Environment Legal issues Lemborexant Levetiracetam Lewy Body Dementia LGBT LGBTQ+ Life coaching Life expectancy Light and Dark Therapy Light therapy Lightbox Liraglutide Literacy Lithium long-acting buprenorphine Longevity lorazepam taper Low calorie refeeding Low libido low sodium Lumateperone Lurasidone Lyrica magnetic seizure therapy (MST) maintenance ECT Malingering Malnourishment Management Mania Mania on Antidepressants MAOIs Marijuana MDMA Media Medical Comorbidities medical comorbidity medical conditions Medical incapacity hold Medication Medication adherence medication capacity hold Medication for Opioid Use Disorder Medication for Opioid Use Disorder (MOUD) medication of opioid use disorder (MOUD) medications medicinal cannabis Melatonin Memantine memory loss Mental Health Meta-analysis Metabolic syndrome Metformin Methadone Methamphetamines methylfolate methylphenidate Microglia Micronutrients mild cognitive impairment Mind-Gut Connection mindful eating Mindfulness Minocycline Minority Mirtazapine Mixed Features MMSE MOCA Modafinil Mood mood disorders Mood stabilizer Mood Stabilizers Mortality Motivational Interviewing MRI MTA MTHFR muscle dysmorphia Mydayis Naloxone Naltrexone Narcolepsy Natural Medications natural treatments Naturalistic Developmental-Behavioral Intervention NDBI Negative Symptoms Negative symptoms of schizophrenia Netflix neuroleptic malignant syndrome Neurology Neuromodulation Neuropsychological testing Neuroscience in Psychiatry Neurotoxicity New York newborn News of Note nicotine Nightmares NMDA NNH NNT Nomogram Non-pharmacologic Non-suicidal self-injury Norepinephrine Nortriptyline Novel drug Novel Medications Nuedexta null hypothesis number needed to harm number needed to treat Nuplazid Nurses Nutrition Nuvigil Obesity observational study obsessions Obsessive Compulsive Disorder Obsessive compulsive disorder/OCD OCD olanzapine Omega-3 Online Learning online therapy Open Label open label trial Opioid antagonist Opioid epidemic Opioid Use Disorder Opioids oppositional behavior Oral Contraceptives Orexin Orthostasis Osmolality Osteporosis OUD Outcome tracking Outcomes Outpatient Over the counter Over the counter medication Overdiagnosis Overdose Oxcarbazepine p-value Pain pandemic Panic Disorder Parent Training Parenting Strategies Parents Parkinson’s Parkinson’s Disease Paroxetine Particulate matter Patch Patient relationship PCL-5 pediatric Pediatric Acute Onset Neuropsychiatric Syndrome (PANS) Pediatric Autoimmune Neurologic Disorder Associated with Streptococcus (PANDAS) Pedophilic Disorder Performance Enhancing Substances perinatal Perseveration Perseverative Behavior Personality Disorders PET Scan Pharmaceutical Industry Pharmacogenomics Pharmacology Pharmacology Tips Pharmacotherapy Pharmacy Phendimetrazine Phentermine phonemic awareness Phonics Physician assisted suicide Pica PICOT Pimozide Pitolisant Podcast polypharmacy post traumatic stress disorder post-exposure prophylaxis Post-hoc Analysis ADHD Rating Scale-5 Post-menopausal Post-stroke depression Posterior Probability Postpartum Depression postpartum mood Potency Practice management Practice Tools and Tips Practice Tools and Tips Pramipexole Prazosin Pregabalin Pregnancy pregnancy testing Prepubescent children prescribing patterns Prescription costs prevalence Prevention Primary care primary outcome Prison Privacy Prodrome Prolactin Prolonged exposure Promethazine Promotoras Pronouns Provigil Prozac pseudobulbar affect Psilocybin Psychedelics psychiatric emergencies Psychiatric interviewing Psychoanalysis Psychodynamic therapy Psychological First Aide Psychopharm Myths Psychopharmacology Psychopharmacology Tips Psychosis Psychotherapy Psychotherapy Psychotic Agitation Psychotic Depression psychotic disorders Psychotropic medication PTSD Public health Qelbree Quality of care quality of life Quetiapine Quillivant Race Raloxifene Randomized controlled trial randomized discontinuation design rapid naming Rapid-acting RCT Reading Reading disorder Reading Disorders Reading remediation recovery time Red Cross Refeeding syndrome Registered Articles Relationships Remediation Repetitive Behavior Repetitive behaviors replication reporting requirements Research Research Update Research Updates Respectful Care restraints restrictive dieting retarded vs excited catatonia retention Retirement retrograde amnesia Riluzole Risk Risk Management Risk of Addiction Risperidione Risperidone Ritalin rTMS Safe Consumption Site safety Safety Planning Saffron SAINT protocol SAMe Samidorphan Saphris Schizoaffective disorder Schizophrenia School Phobia School Refusal screening ScreeninGeg Seasonal Affective Disorder seclusion Second Generation Antipsychotics (SGAs) secondary outcome Secuado Self-injury Self-Regulation Semaglutide Separation Separation Anxiety SERM (Selective Estrogen Receptor Modulator) Serotonin Serotonin Norepinephine Reuptake Inhibitors Serotonin Specific Reuptake Inhibitors Serotonin Specific Reuptake Inhibitors (SSRIs) Sertraline Sex offenders Sex Therapy Sexual Abuse Sexual Dysfunction sexual intercourse Sexual Side Effects sexually transmitted diseases SIADH Side Effects Silexan Skype Sleep Sleep Apnea Sleep Disorders Sleep Onset Insomnia SLUMS Smoking Cessation Smoking Cessation Agents smoking cessations SNRIs Social Anxiety Social Anxiety Disorder social cohesion sodium supplementation Somnambulism Special populations Specific Phobia SSRIs statistical significance Statutes Stereotypical Behavior steroids STI screening Stigma stimulant Stimulant Medications Stimulant treatment Stimulant use disorder Stimulants Stroke structured literacy Suboxone Substance Abuse Substance Abuse Substance Use Substance Use Disorder Substance use disorders Suicidality Suicide Sundowning Supplementation Supplements Surrogate decision-maker Suvorexant Swallowing Symptom Assessment Symptom Management Systematic review Tags Tantrums taper Tarasoff Tardive dyskinesia Technology Teen teens Telehealth Telemed Telemedicine Telepsychiatry test cme quiz testifying Tetrabenazine TFCBT TGD Therapy during medication appointment Therapy with Med Management Theta burst stimulation tics TMS Tobacco tobacco research Tobacco use disorder Top 10 Podcasts of 2021 Topiramate Toxic Stress Transcranial direct current stimulation (TDCS) Transcranial Magnetic Stimulation Transdermal Transgender Translator transplant surgery Trauma Trauma Informed Care Trauma-focused psychotherapy Traumatic Brain Injury (TBI) Trazodone treatment treatment efficacy treatment pediatric Treatment planning Treatment-Resistant Depression Trigeminal Nerve Stimulation Trintellix unblinded Understanding Psychiatric Research unilateral vs bilateral urinary difficulties urinary tract infections urine toxicology UTI Vagus nerve stimulation (VNS) Valbenazine Valproate Vaping Varenicline Venlafaxine verbal de-escalation videogaming addiction Viloxazine Violence Vitamin B12 Vitamin B6 Vitamin D Vitamin E VMAT2 Inhibitors Vortioxetine Vyleesi Vyvanse Waist circumference Wakix water intoxication water restriction Weed Weight gain Weight Loss Medications Weiss Functional Impairment Rating Scale-Parent (WFIRS-P) Wellbutrin whey protein powders White matter hyperintensities Whole Genome Sequencing Wilderness Therapy Programs Withdrawal women Women's Issues in Psychiatry Women’s Issues in Psychiatry Working With Families workplace Xenazine Youth Z-drugs Zenzedi and ProCentra Ziprasidone Toggle navigation HOME STORE CME CENTER Blog Podcast NEWSLETTERS The Carlat Psychiatry Report The Carlat Child Psychiatry Report The Carlat Addiction Treatment Report The Carlat Hospital Psychiatry Report The Carlat Geriatric Psychiatry Report Archive Archive Archive Archive Archive IDEA IDEA Clinical Update School Inclusion: What You Need to Know From The Carlat Child Psychiatry Report, Assessment in Children and Adolescents Topics: Free Articles | IDEA | Inclusion | Inclusion strategies | Independent Educational Plan (IEP) | Least Restrictive Environment Yamila is a 9-year-old autistic 3rd grader from a Spanish-speaking home with an individualized education plan (IEP) who attends a special education classroom with seven other students. She is a role model for her peers, compliant and never complaining. For two months Yamila has often been absent with stomachaches. After an extensive workup, Ya Read More Subscribe Register for free content × Register For Free Articles Register to receive free email newsletters with concise, practical advice for busy clinicians. You will also have access to select article content on the website and you will receive notifications of new books and special discount offers. First Name Last Name Email Address Website Close Courses and Book CME Medication Fact Book for Psychiatric Practice, Sixth Edition (2022) 2022 Carlat Psychiatry Report Self-Assessment Course Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics The Child Medication Fact Book for Psychiatric Practice (2018) Issues Archives 2022 Eating Disorders in Children and Adolescents (July/August/September) ADHD in Children and Adolescents (April/May/June) Assessment in Children and Adolescents (January/February/March) 2021 Overarousal in Children and Adolescents (Oct/Nov/Dec) Substance Use in Children and Adolescents (Jul/Aug/Sep) Autism in Children and Adolescents (April/May/June) Clinical Complexity With Children and Adolescents (Jan/Feb/Mar) 2020 Esketamine (January) Telepsychiatry (May) Mind-Gut Connection (January) Practical Psychotherapy (November/December) Mood and Menopause (October) When to Use Lithium (September) Traumatic Brain Injury (August) Borderline Personality Disorder (June/July) Psychopharmacology Algorithms (April) Bipolar II (March) Inflammation and Depression (February) 2020 Mood Disorders in Children and Adolescents (Oct/Nov/Dec) Identity & Culture in Children and Adolescents (July/August/September) Psychosis in Children and Adolescents (April/May/June) ADHD in Children and Adolescents (Jan/Feb/Mar) 2020 Harm Reduction (January/February) Substance Use in Health Professionals (March/April) Alternative Treatment in Addiction (November/December) Social Aspects of Addiction (September/October) Opioid Use Disorder Treatment (July/August) Emerging Risks for Old Medications (May/June) 2019 Depression (May) Adult ADHD (November/December) Mental Health Apps (October) How to Talk about Medication (September) Side Effects Part II (August) Side Effects Part I (June/July) Sleep (April) Parenting, Pregnancy, and Prevention (March) Dark and Light Therapy (February) Deprescribing (January) 2018 Drug Metabolism (November/December) Working With Transgender Patients (October) Emergency Psychiatry (September) Treatment-Resistant Depression (July/August) Neurobiology (June) Anxiety (May) Neurofeedback (April) Antipsychotics Update (March) Working With Families (February) Bipolar Disorder (January) 2017 PTSD (December) Retirement (November) Intellectual Disability (September/October) Antidepressants (July/August) Personality Disorders (June) Dementia (May) Cognitive Behavior Therapy Techniques (April) Pharmacogenetics (March) Treating Psychosis (February) Adult ADHD (January) 2016 Complementary and Alternative Medicine in Psychiatry (November/December) Side Effects (October) Pain Management (September) Medication in Pregnancy (July/August) Psychoanalysis in Modern Psychiatry (June) Correctional Psychiatry (May) Antidepressant Roundup (April) Burnout (March) Private Practice (February) Bipolar Disorder (January) 2015 Psychiatry and General Medicine (November/December) Biomarkers in Psychiatry (May) Telepsychiatry (October) Sleep Disorders (September) Interventional Psychiatry (July/August) Eating Disorders (June) Psychotherapy Updates (April) Topics in Geriatric Psychiatry (March) Antipsychotics Update (February) Risk Management (January) 2014 Bipolar Disorder (November/December) Pharmacogenetics (October) Keeping up in Psychiatry (September) Research in Psychiatry (July/August) Marijuana (June) Psychiatric Diagnosis (May) Issues in Psychopharmacology (April) Schizophrenia (March) Women’s Psychiatry (February) Ethics in Psychiatry (January) 2013 Military Psychiatry (December) Depression (November) Treatment of Dementia (October) Anxiety Disorders (September) Natural and Alternative Treatments in Psychiatry (July/August) Autism Spectrum Disorder (June) Practice Tips (May) Substance Abuse (April) Medicolegal Topics (March) End of Life Care (February) Antipsychotic Update (January) 2012 Screening Tools and Tips (December) Medical Comorbidities (November) Devices in Psychiatry (October) Eating Disorders (September) Bipolar Disorder (July/August) Risk Management (June) Antidepressant Roundup 2012 (May) Gender and Sexuality (April) Personality Disorders (March) ADHD (February) Natural Treatments in Psychiatry (January) 2011 Electronic Medical Records (December) Insomnia (November) Psychotherapy (October) Alcoholism (September) Anxiety Disorders (July/August) Schizophrenia (June) Managing Side Effects (May) Antidepressant Roundup 2011 (April) DSM-5 and Diagnostic Issues (March) Drug-Drug Interactions (February) Bipolar Disorder (January) 2010 Hospital Psychiatry (December) Psychiatric Medication in Pregnancy (November) Maintenance of Certification (October) The Neuroscience of Psychotherapy (September) Treatment of Depression (July/August) Email and the Internet in Psychiatry (June) Substance Abuse (May) The Diagnosis and Treatment of Dementia (April) Ethics in Psychiatry (March) Natural Treatments in Psychiatry (February) ADHD (January) 2009 Treating Schizophrenia (December) Treatment for Anxiety Disorders (November) The Latest on Antidepressants (October) Topics in Neuropsychiatry (September) The Interface of Medicine and Psychiatry (July/August) Generic Medications in Psychiatry (June) The Treatment of Eating Disorders (May) Healthcare Policy and Psychiatry (April) Antipsychotic Roundup 2009 (March) Psychiatric Medication in Pregnancy and Lactation (February) Transcranial Magnetic Stimulation (January) 2008 Treating Fibromyalgia and Pain in Psychiatry (December) Issues in Child Psychiatry (November) Improving Psychiatric Practice (October) Treating Personality Disorders (September) Bipolar Disorder (July/August) Antipsychotic Roundup 2008 (June) Atypical Antipsychotics in Clinical Practice (February) Neuropsychological Testing (May) Psychiatric Medications: Effects and Side Effects (April) Update on Substance Abuse (March) Anticonvulsants in Psychiatry (February) Brain Devices in Psychiatry (January) 2007 The Treatment of Insomnia (December) Avoiding Malpractice in Psychiatry (November) Update on Eating Disorders (October) Complex Psychopharmacology (September) Laboratory Testing in Psychiatry (August) Psychotherapy in Psychiatry (July) Posttraumatic Stress Disorder (June) Topics in Geriatric Psychiatry 2007 (May) Pregnancy and Menopause in Psychiatry (Apil) Antipsychotic Roundup 2007 (March) Understanding Psychiatric Research (February) Antidepressant Round-up 2007 (January) 2006 Technology and Psychiatric Practice (December) The Use of MAOIs (November) Medication Treatment of Depression (January) Seasonal Affective Disorder (October) Treatment of ADHD (September) Topics in Bipolar Disorder (August) Neurotransmitters in Psychiatry (July) Treating Substance Abuse (June) The STAR*D Antidepressant Trial (May) Natural Treatments in Psychiatry (April) Medication Treatment of Anxiety (March) Panic Disorder: Making Treatment Work (March) Antipsychotic Roundup 2006 (February) Antidepressant Roundup 2006 (January) 2005 Self-Help Books and Psychiatry (December) Genetics and Psychiatry (November) Pregnancy and Psychiatric Treatment (October) Benzodiazepines and Hypnotics in Psychiatry (September) Geriatric Psychiatry Update (August) Chart Documentation in Psychiatry (July) The Treatment of Bipolar Disorder (June) Weight Loss and Smoking Cessation in Psychiatry (May) Treating ADHD (April) Drug Industry Influence in Psychiatry (March) Atypical Antipsychotics 2005 (February) Antidepressant Roundup 2005 (January) 2004 Sexual Dysfunction (December) Suicide Prevention (November) To Sleep, To Awake (October) Women’s Issues in Psychiatry (September) OCD: An Update (August) Chronic Pain and Psychiatry (July) Neuroimaging in Psychiatry (June) Natural Medications in Psychiatry (May) Posttraumatic Stress Disorder (April) Treatment of Alcoholism (March) Battle of the Atypicals (February) Antidepressant Roundup, 2004 (January) 2003 Research Methods in Psychiatry (December) Antidepressants in Children (November) The Treatment of Dementia (October) Bipolar Disorder, Part II: The Novel Anticonvulsants (September) Bipolar Disorder: The Basics (August) Drug-Drug Interactions in Psychiatry (July) Managing Antidepressant Side Effects (June) Antidepressants in Pregnancy and Lactation (May) ADHD: Medication Options (April) Panic Disorder: Making Treatment Work (March) Atypical Antipsychotics in Clinical Practice (February) Medication Treatment of Depression (January) 2019 Autism in Children and Adolescents (November/December) Depression in Children and Adolescents (May/June/July/August) Substance Use in Children and Adolescents (September/October) Trauma in Children and Adolescents (March/April) Anxiety in Children and Adolescents (January/February) 2018 Psychotropic Risks in Children and Adolescents (May/June) ADHD in Children and Adolescents (November/December) Depression in Children and Adolescents (September/October) Autism in Children and Adolescents (July/August) Anxiety in Children and Adolescents (March/April) Suicide in Children and Adolescents (January/February) 2017 Adolescents (November/December) ADHD in Children and Adolescents (September/October) Psychosis in Children and Adolescents (August) PANDAS, PANS, and Related Disorders (June/July) Marijuana in Children and Adolescents (May) Tourette’s and Other Tic Disorders in Children and Adolescents (March/April) Autism in Children and Adolescents (January/February) 2016 Gender Dysphoria in Children and Adolescents (November/December) Technology Issues With Children and Adolescents (September/October) Mood Dysregulation in Children and Adolescents (July/August) Eating Disorders in Children and Adolescents (May/June) Conduct Disorder in Children and Adolescents (April) Sleep Disorders in Children and Adolescents (March) ADHD in Children and Adolescents (January/February) 2015 Antidepressant Use in Children (November/December) Foster Care and Child Psychiatry (September/October) Autism (July/August) Trauma (May/June) Anxiety Disorders (April) Schools and Psychiatry (March) Emergency Psychiatry in Children (January/February) 2014 Antipsychotics in Children (December) ADHD (November) Gender and Sexuality (September/October) Psychotic Symptoms (Summer) Medication Side Effects (May) Food and Mood (April) Learning and Developmental Disabilities (February) 2013 Complex Practice Issues (December) Diet and Nutrition (November) Child Psychiatry in DSM-5 (August/September) Medication Side Effects and Interactions (June/July) Problematic Technology (March/April) Autism Spectrum Disorders (January/February) 2012 Bipolar Disorder (December) Substance Abuse (October/November) Transitional Age Youth (July/August) Rating Scales (May/June) Eating Disorders (March/April) Behavioral Disorders (February) 2011 Treatment of Anxiety Disorders (December) Trauma (November) Bullying and School Issues (October) Hidden Medical Disorders (August) OCD and Tic Disorders (June) Suicide and Non-Suicidal Self Injury (April) Sleep Disorders (March) ADHD (January) 2010 Use of Antipsychotics in Children and Adolescents (December) Learning and Developmental Disabilities (October) Major Depression (September) Treating Children and Families (July) The Explosive Child (May) 2019 Dual Diagnosis in Addiction Medicine (May/June) Medical Issues in Addiction Practice (November/December) Alcohol Addiction (September/October) Legal Issues in Addiction Medicine (July/August) Traumatic Brain Injury and Addiction (March/April) Board Certification in Addiction Medicine (January/February) 2018 Opioid Addiction (November/December) Addiction in Older Adults (October) Sleep Disorders and Addiction (September) Adolescent Addiction (July/August) Pain and Addiction (May/June) Cannabis and Addiction (March/April) Stigma and Addiction (January/February) 2017 Pregnancy and Addiction (November/December) Detox (Sepember/October) Dual Diagnosis (August) Alternatives to 12-Step Programs (June/July) Recovery (May) Psychiatric Uses of Street Drugs (March/April) Sex Addiction (January/February) 2016 Prescription Drug Monitoring Programs (PDMPs) (November/December) Addiction in Health Care Professionals (September/October) Dialectical Behavior Therapy in Addiction (August) Motivational Interviewing (June/July) Benzodiazepines (May) Opioid Addiction (March/April) Families and Substance Abuse (January/February) 2015 The Twelve Steps (November/December) Designer Drugs (September/October) Residential Treatment Programs Decoded (July/August) Nicotine and E-Cigarettes (June) Drug Screening (April/May) Integrating Therapy and Medications for Alcoholism (March) Detoxification Protocols (January/February) 2014 Behavioral Addictions (December) Risk and Reimbursement (November) Stimulant Abuse (September/October) Self-Help Programs (June) Opioid Addiction (May) Coping with Bad Outcomes (March) Change Management in Addiction Treatment (January/February) 2013 Cocaine Addiction (December) Relapse Prevention (November) Cannabis Addiction (August/September) Addiction in DSM-5 (June/July) Editor-in-Chief Joshua D. Feder, MD Dr. Joshua Feder studied mathematics and medicine at Boston University, Psychiatry at Naval Regional Medical Center San Diego, serving the first gulf war in child and adolescent psychiatry fellowship at Tripler Army Medical Center in Honolulu, and eventually becoming Chief of Child Psychiatry at the National Naval Medical Center in Bethesda, MD. Dr. Feder now practices in Solana Beach, California and serves as Medical Director at Positive Development, providing relationship-based support for families, with research at UCSD, SDSU, Fielding Graduate University, An Najah National University, Quicksilver Software, Autism Is inclusion program, and Programmatic Lead for the International Networking Group on Peace Building with Young Children, with projects in the US, Northern Ireland, and the Middle East. Dr. Feder co-authored the first American Academy of Child & Adolescent Psychiatry Practice Parameter on Autism and serves on the Disaster & Trauma Committee and the Resource Group on Youth at the Border. Dr Feder was founding policy chair for the California Association for Infant Mental Health, and advocates worldwide on access to care, climate policy, and peacebuilding. His recent books include Child Medication Fact Book for Psychiatric Practice (2018) and Prescribing Psychotropics (2021). Full Editorial Information About About Us CME Center FAQ Contact Us Shop Online Subscriptions Books Online Courses Newsletters The Carlat Psychiatry Report The Carlat Addiction Treatment Report The Carlat Child Psychiatry Report The Carlat Hospital Psychiatry Report Contact info@thecarlatreport.com 866-348-9279 PO Box 626, Newburyport MA 01950 Follow Us © 2022 Carlat Publishing, LLC and Affiliates, All Rights Reserved. Please see our Privacy Policy and the Hardware/Software Requirements to view our website. ×